Royalty Report: Tobacco, Cannabis, Therapeutic – Collection: 230687


Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 4


This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4

Primary Industries

  • Tobacco
  • Cannabis
  • Therapeutic

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 230687

License Grant
The Company granted the Licensee a non-exclusive license to manufacture, sell, and distribute products within California using proprietary product formulations owned or licensed by the Company.  This is in exchange for Licensee not contracting with a competitor of the Company who provides formulation services, smart vape device hardware and related software applications to its network, product branding or access to reporting from its data set that ties a user’s experience to a chemical profile of the product they are consuming.
License Property
Licensor is a science and technology company that develops and deploys products and services in the following focus areas

1) Consumer Products – smart devices and consumables

2) Data Analytics – pre-clinical chemical analysis and patient feedback ecosystem

3) Biopharmaceuticals – identifying ‘green Active Pharmaceutical IngredientsTM, (gAPITM) and corresponding formulations

4) Software as a Service (SaaS) – Software services for prescribers, patient groups, cultivators, and regulators

Field of Use
This agreement pertains to the drug industry.  The Licensee currently operates a manufacturing and distribution facility, licensed by the state of California, through which it engages in the sale and distribution of various cannabis related products.

This is in exchange for Licensee not contracting with a competitor of the Licensor who provides formulation services, smart vape device hardware and related software applications to its network, product branding or access to reporting from its data set that ties a user’s experience to a chemical profile of the product they are consuming.

IPSCIO Record ID: 371743

License Grant
Licensees will work in conjunction with Licensor, as exclusive distributor, to expand the Licensor brand to the states of Oklahoma and South Dakota using Licensee’s distribution channels. Under the terms of the signed agreement, Licensor will provide Licensees with technical information, product formulations, and the licensed service marks necessary to promote and distribute the Licensor products. Licensee will also provide manufacturing and packaging of the Licensor products for distribution in Oklahoma and South Dakota.
License Property
Products include THC and cannabis vape products under the BLVK Brand.
Field of Use
The agreement pertains to the cannabis industry.

IPSCIO Record ID: 345624

License Grant
Licensor hereby engages Licensee, on a non-exclusive basis, and Licensee hereby accepts such engagement and agrees, upon the terms and conditions set forth herein, to provide the Cultivation Services pursuant to the terms and conditions set forth herein. Licensee hereby is granted the right to develop, manage, and produce on behalf of Licensor all Licensee-branded products, including but not limited to those set forth; provided, however, that (a) Licensee is authorized by Licensor to produce all products that may be lawfully grown and distributed in Nevada pursuant to applicable law, including CCB guidelines and the RTMA; (b) Licensee shall use commercially-reasonable efforts to maximize the production and sales of the products grown at the Cultivation Facility under this Agreement, subject to compliance with all applicable laws; (c) Licensee shall commence making its improvements to the Designated Acreage within 120 calendar days of the date of the Commencement Notice and shall begin cultivation on the Designated Acreage (as evidenced by registration of the first plants with the CCB) by the first day of Spring following the Commencement Notice or when the CCB approves cultivation activities at the Designated Acreage, whichever occurs later; and (d) Licensee complies with all applicable laws, rules, and regulations, including but not limited to those pertaining to the labeling of product sold hereunder.
License Property
Product shall include but not limited to Cannabis / Marijuana on the Designated Acreage and selling in the State of Nevada.
Field of Use
Field of use is for a cultivation facility license to cultivate (grow), process, and package marijuana; sell marijuana to retail marijuana stores; and operate marijuana product manufacturing facilities and sell to other cultivation facilities.

IPSCIO Record ID: 365304

License Grant
Various Licensees operate a state-of-the-art cannabis cultivation, processing and manufacturing facility from the Licensor.
License Property
The facility is used for development, traditional horticulture, lean manufacturing, medical research, facility construction, regulatory compliance, security, marijuana cultivation and genetics, extraction processes, and infused product development.
Field of Use
Field of use is for medical cannabis and the newly emerging adult-use cannabis marketplace.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.